SpectraScience Inc SCIE
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $0.00
- Day Range
- $0.00–0.00
- 52-Week Range
- $0.00–0.00
- Bid/Ask
- $0.00 / $0.00
- Market Cap
- $4,923.80
- Volume/Avg
- 5,650 / 1.6 Mil
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
SpectraScience Inc is a US based company focused on developing the WavSTAT Optical Biopsy System (WavSTAT). The WavSTAT employs a risk technology that optically illuminates tissue in real-time to distinguish between normal and pre-cancerous or cancerous tissue. The firm has developed a technology platform to determine if the tissue is normal, pre-cancerous or cancerous, without the need for a physical biopsy. The WavSTAT operates by using cool, safe UV laser light to optically illuminate and analyze tissue, enabling the physician to make a diagnosis during endoscopy when screening for cancer and, if warranted, to begin treatment during the same procedure. The group sells its product in the United States and Europe, of which majority of the sales revenue is derived from the United States.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Value
- Total Number of Employees
- 9
- Website
- http://www.spectrascience.com
Valuation
|
Metric
|
SCIE
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
SCIE
|
|---|---|
Quick Ratio | 0.00 |
Current Ratio | 0.02 |
Interest Coverage | −2.26 |
Quick Ratio
SCIE
Profitability
|
Metric
|
SCIE
|
|---|---|
Return on Assets (Normalized) | −352.38% |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | — |
Return on Assets
SCIE
Medical Devices Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ABT
| Abbott Laboratories | Mzwnstjyq | Sjxxjx | $185.8 Bil | |
SYK
| Stryker Corp | Hsvtswxbf | Dfpjt | $127.4 Bil | |
MDT
| Medtronic PLC | Lkbwxjbd | Vgvmlf | $105.2 Bil | |
BSX
| Boston Scientific Corp | Jcdpcjqsz | Ztdqz | $99.0 Bil | |
DXCM
| DexCom Inc | Jyjghfls | Ygycm | $53.1 Bil | |
EW
| Edwards Lifesciences Corp | Xmlnlmyfrl | Qfqqrfb | $52.8 Bil | |
ZBH
| Zimmer Biomet Holdings Inc | Fgtsyxgdt | Nzpmc | $25.0 Bil | |
ALGN
| Align Technology Inc | Rphkszc | Zxmbb | $23.5 Bil | |
PHG
| Koninklijke Philips NV ADR | Nqpywmb | Mxsqkq | $18.5 Bil | |
PODD
| Insulet Corp | Lthlcjxkg | Gtlbb | $11.7 Bil |